Zusammenfassung
Einleitung: Chronische Suizidgedanken sind in der klinischen Praxis verbreitet. Gleichwohl finden sich in der Literatur nur wenige Hinweise zum therapeutischen Umgang mit chronischen Suizidgedanken. Methode: Aufbauend auf der Idee, dass Verstärkungsprozesse für die Persistenz von Suizidgedanken hochrelevant sind und anhaltende Suizidgedanken für Betroffene teils positiv konnotiert sind, wird im vorliegenden Artikel ein Behandlungsvorschlag abgeleitet. Ergebnisse: Hierbei werden Elemente der explizit-fokussierten Ambivalenzarbeit verknüpft mit Therapieelementen aus der metakognitiven Therapie bzw. der Akzeptanz- und Commitment-Therapie. Diskussion/Schlussfolgerung: Es wird betont, dass der Umgang mit chronischen Suizidgedanken eine andere therapeutische Herangehensweise erfordert als der Umgang mit akuten Suizidgedanken.
Literatur
1.
Bernal
M
, Haro
JM
, Bernert
S
, Brugha
T
, de Graaf
R
, Bruffaerts
R
, Risk factors for suicidality in Europe: results from the ESEMED study
. J Affect Disord
. 2007
;101
:27
–34
. .2.
Britton
PC
, Bryan
CJ
. Motivational Interviewing for means restriction counseling with patients at risk for suicide
. Cog Behav Prac
. 2016
;23
:51
–61
.3.
Britton
PC
, Conner
KR
, Maisto
SA
. An open trial of motivational interviewing to address suicidal ideation with hospitalized veterans
. J Clin Psychol
. 2012
;68
:961
–71
. .4.
Britton
PC
, Conner
KR
, Chapman
BP
, Maisto
SA
. Motivational interviewing to address suicidal ideation: a randomized controlled trial in veterans
. Suicide Life Threat Behav
. 2020
;50
:233
–48
. .5.
Britton
PC
, Patrick
H
, Wenzel
A
, Williams
G
. Integrating motivational interviewing and self determination theory with cognitive behavioral therapy to prevent suicide
. Cogn Behav Pract
. 2011
;18
:16
–27
. .6.
Crane
C
, Barnhofer
T
, Duggan
DS
, Eames
C
, Hepburn
S
, Shah
D
, Comfort from suicidal cognition in recurrently depressed patients
. J Affect Disord
. 2014
;155
:241
–6
. .7.
Crane
C
, Shah
D
, Barnhofer
T
, Holmes
EA
. Suicidal imagery in a previously depressed community sample
. Clin Psychol Psychother
. 2012
;19
:57
–69
. .8.
Czyz
EK
, King
CA
, Biermann
BJ
. Motivational interviewing-enhanced safety planning for adolescents at high suicide risk: a pilot randomized controlled trial
. J Clin Child Adolesc Psychol
. 2019
;48
:250
–62
. .9.
DeCou
CR
, Comtois
KA
, Landes
SJ
. Dialectical behavior therapy is effective for the treatment of suicidal behavior: a meta-analysis
. Behav Ther
. 2019
;50
:60
–72
. .10.
Ducasse
D
, Jaussent
I
, Arpon-Brand
V
, Vienot
M
, Laglaoui
C
, Béziat
S
, Acceptance and commitment therapy for the management of suicidal patients: a randomized controlled trial
. Psychother Psychosom
. 2018
;87
:211
–22
. .11.
Forkmann
T
, Brähler
E
, Gauggel
S
, Glaesmer
H
. Prevalence of suicidal ideation and related risk factors in the German general population
. J Nerv Ment Dis
. 2012
;200
:401
–5
. .12.
Forman
EM
, Berk
MS
, Henriques
GR
, Brown
GK
, Beck
AT
. History of multiple suicide attempts as a behavioral marker of severe psychopathology
. Am J Psychiatry
. 2004
;161
:437
–43
. .13.
Franklin
JC
, Ribeiro
JD
, Fox
KR
, Bentley
KH
, Kleiman
EM
, Huang
X
, Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research
. Psychol Bull.
2017
;143
:187
–232
. .14.
15.
Garakani
A
, Buono
FD
, Larkin
K
, Polonsky
M
, Goldberg
JF
. Development and validation of a new scale to measure chronic suicidal ideation
. J Psychiat Res
. 2022
;150
:160
–164
.16.
17.
18.
Hennings
JM
. Das Verstärkermodell der Suizidalität: Chronische Suizidalität bei der Borderline-Persönlichkeitsstörung verstehen und behandeln
. Verhaltenstherapie
. 2021
;31
:286
–97
. .19.
Hennings
JM
. Chronische Suizidalität – eine besondere Form der Suizidalität
. Nervenheilkunde
. 2022
;41
:230
–39
. .20.
Jacobs
D
, Brewer
M
. APA Practice Guideline provides recommendations for assessing and treating patients with suicidal behaviors
. Psych Ann
. 2004
;34
:373
–80
. .21.
Jobes
DA
, Joiner
TE
. Reflections on suicidal ideation
. Crisis
. 2019
;40
:227
–30
. .22.
Joiner
TE
. The perversion of virtue: Understanding murder-suicide
. Oxford, UK
: Oxford University Press
; 2014
.23.
Kirtley
O
, Rodham
K
, Crane
C
. Understanding suicidal ideation and behaviour in individuals with chronic pain: a review of the role of novel transdiagnostic psychological factors
. Lancet Psychiatry
. 2020
;7
:282
–90
. .24.
Kleiman
EM
, Coppersmith
DDL
, Millner
AJ
, Franz
PJ
, Fox
KR
, Nock
MK
. Are suicidal thoughts reinforcing? A preliminary real-time monitoring study on the potential affect regulation function of suicidal thinking
. J Affect Disord
. 2018
;232
:122
–6
. .25.
Koban
C
, Teismann
T
. Psychotherapie mit suizidalen Patienten: Verstehen und Verbessern der motivationalen Ausgangslage
. Psychotherapie Aktuell
. 2017
;9
:24
–31
.26.
Linehan
M
. Dialektisch-Behaviorale Therapie der Borderline-Persönlichkeitsstörung
. München
: CIP-Medien
; 1996
.27.
28.
Miller
WR
, Rollnick
S.
Motivierende Gesprächsführung.Freiburg
: Lambertus
; 2015
.29.
Paris
J
. Half in love with death: managing the chronic suicidal patient
. London, UK
: Routledge
; 2007
.30.
Paris
J
. Suicidality in borderline personality disorder
. Medicina
. 2019
;55
:223
–8
. .31.
Perry
JC
, Perry
JC
, Fowler
A
, Fowler
AJ
, Bailey
EM
, Clemence
B
, Improvement and recovery from suicidal and self-destructive phenomena in treatment-refractory disorders
. J Nerv Ment Dis
. 2009
;197
:28
–34
. .32.
Prochaska
JO
, DiClemente
CC
. Stages and processes of self-change of smoking: toward an integrative model of change
. J Consult Clin Psychol
. 1983
;51
:390
–5
. .33.
Rath
D
, Teismann
T
, Höller
I
, Glaesmer
H
, Paashaus
L
, Schönfelder
A
, Predicting suicidal ideation in a longitudinal high-risk sample: multilevel analyses and 12-month trajectories
. J Clin Psychol
. 2021
;77
:2353
–369
.34.
Rudd
MD
, Joiner
TE
, Rajab
MH
. Relationships among suicide ideators, attempters, and multiple attempters in a young-adult sample
. J Abnorm Psychol
. 1996
;105
:541
–50
. .35.
Selby
EA
, Anestis
MD
, Joiner
TE
. Daydreaming about death: Violent daydreaming as a form of emotion dysregulation in suicidality
. Behav Modif
. 2007
;31
:867
–79
. .36.
Simons
M
. Metakognitive Therapie mit Kindern und Jugendlichen
. Weinheim, Germany
: Beltz
; 2018
.37.
Stiegelmayr
C
, Gunia
H
. Dialektisch-behaviorale Therapie zur Behandlung der Borderline-Persönlichkeitsstörung
. Göttingen, Germany
: Hogrefe
; 2017
.38.
Teismann
T
, Forkmann
T
, Glaesmer
H
, Egeri
L
, Margraf
J
. Remission of suicidal thoughts: Findings from a longitudinal epidemiological study
. J Affect Disord
. 2016a
;190
:723
–5
. .39.
Teismann
T
, Forkmann
T
, Michalak
J
, Brailovskaia
J
. Repetitive negative thinking about suicide: associations with lifetime suicide attempts
. Clin Psychol Eur
. 2021
;3
:e5579.40.
Teismann
T
, Koban
C
, Illes
F
, Oermann
A
. Psychotherapie suizidaler Patienten
. Göttingen, Germany
: Hogrefe
; 2016b
.41.
Tighe
J
, Nicholas
J
, Shand
F
, Christensen
H
. Efficacy of acceptance and commitment therapy in reducing suicidal ideation and deliberate self-harm: systematic review
. JMIR Ment Health
. 2018
;5
:e10732. .42.
Tullis
K
. A theory of suicide addiction
. Sex Addict Compuls
. 1998
;5
:311
–24
.43.
Wells
A
. Metakognitive Therapie bei Angststörungen und Depression
. Weinheim, Germany
: Beltz
; 2011
.44.
Wenzel
A
, Brown
GK
, Beck
AT
. Cognitive therapy for suicidal patients
. Washington
: APA
; 2009
.45.
Williams
JMG
, Fennell
M
, Barnhofer
T
, Crane
R
, Silverton
S
. Mindfulness-based cognitive therapy with people at risk of suicide
. New York
: Guilford Press
; 2017
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
